Introduction of Careprost Plus Eye Drop
Careprost Plus is composed of two active substances of a different class of drugs namely Bimatoprost and Timolol. Both the active ingredients work together to reduce pressure in the eye. Bimatoprost is an ocular hypotensive active agent, a synthetic prostamide that mimics the effects of a biosynthesized component called prostamides, while Timolol is categorized under the drug class beta blockers. Your eye has a clear, watery liquid that feeds the inside of the eye. This fluid is constantly being drained out, and new liquid is produced to replace this. If the fluid remains inside and does not drain out, there is build up of pressure inside your eye, which could increase the risks of vision loss. This type of eye condition is often called as glaucoma. Bimatoprost and Timolol work to reduce the fluid production as well as increase the amount of fluid that is drained out of the eye. This successfully reduces the pressure within the eye.
Careprost Plus is an ophthalmic solution, which is used to treat high pressure in the eye. This high pressure within the eye is also known as ocular hypertension. Ocular hypertension can lead to glaucoma. The eye medication is an ideal choice for reduction of eye pressure in patients with open-angle glaucoma. An ophthalmologist will prescribe Careprost Plus when a patient does not respond to any other ophthalmic preparations containing prostaglandin analogues or beta blockers. The eye drop solution has a rapid onset of action.
Instructions for the use of Careprost Plus
Use Careprost Plus exactly as your ophthalmologist has told you. Check with your health care specialist if you are not sure about how to use the eye drop. It is recommended to use one drop daily in the affected eye. You can use it either in the morning or in the evening. Try to use it daily at the same time to maintain the continuity.
Make sure that the product bottle is sealed proof otherwise don’t use it.
Wash your hand and eyes before using the eye drop.
Tilt your head, look up, and squeeze the bottle to release one drop in the eye that needs treatment.
Close your eyes, while keeping the eye closed, all you need to do is press your finger against the corner of the closed eye (inside corner of your eye) and hold for two minutes. This action is helpful in stopping the medication getting into the rest of the body.
Don’t let the tip of the bottle touch your eye or any other surface. Put the cap of the bottle immediately after using the medication. If you have been told to use Careprost Plus with other ophthalmic solution, take a gap of at least 5 to 10 minutes between putting Bimatoprost/Timolol and other medicine.
If you forget to use Bimatoprost/Timolol, there is nothing to think about much, what you need to do is use a single drop as an when you remember, and then go back to follow your normal dosing schedule. Avoid using the medication for more than once a day.
When should Careprost Plus not be used?
Careprost Plus is not suitable for patients who have hypersensitivity to the active ingredients or any of the ingredients of the preparation.
It is not meant for people with reactive airway diseases, including bronchial asthma or a family history of bronchial asthma, and severe chronic obstructive pulmonary diseases (COPD).
The use of Careprost plus is contraindicated in people with health conditions like sinoatrial block sinus bradycardia, sick sinus syndrome, cardiac failure, cardiogenic shock, second or third-degree atrioventricular block.
The eye drop should not be given to children and teenagers under 18.
Other medications and Careprost Plus
Careprost Plus can affect or be affected by other pharmaceutical agents you are using, including an ophthalmic solution for getting rid of glaucoma. Let your healthcare specialist know if you are using any other medicine. Especially, inform your healthcare provider if you are using or intend to use drugs to lower blood pressure, diabetes medications, heart medicine, or medicines to treat depression like paroxetine and fluoxetine.
There are no reviews yet.